Hisamitsu Ishihara

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Community Dwelling

Cardiovascular Risk Factors

Top Venues

Therapeutics and clinical risk management

Journal of multidisciplinary healthcare

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Masahiro Takubo, Kentaro Watanabe, Hitoki Saito, Genta Kohno, Hisamitsu Ishihara
Therapy combining glucagon-like peptide-1 receptor agonist with sodium-glucose cotransporter 2 inhibitor suppresses atherosclerosis in diabetic ApoE-deficient mice. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association (2024)
Takeshi Yamamotoya, Yukino Ohata, Yasuyuki Akasaka, Shun Hasei, Masa-Ki Inoue, Yusuke Nakatsu, Machi Kanna, Hiroki Yamazaki, Akifumi Kushiyama, Midori Fujishiro, Hiraku Ono, Hideyuki Sakoda, Tetsuya Yamada, Hisamitsu Ishihara, Tomoichiro Asano
Trk-fused gene plays a critical role in diet-induced adipose tissue expansion and is also involved in thyroid hormone action. PNAS nexus 3 (4) (2024)
Takeshi Yamamotoya, Yukino Ohata, Yasuyuki Akasaka, Shun Hasei, Masa-Ki Inoue, Yusuke Nakatsu, Machi Kanna, Hiroki Yamazaki, Akifumi Kushiyama, Midori Fujishiro, Hiraku Ono, Hideyuki Sakoda, Tetsuya Yamada, Hisamitsu Ishihara, Tomoichiro Asano
Trk-fused gene plays a critical role in diet-induced adipose tissue expansion and is also involved in thyroid hormone action. PNAS nexus 3 (4) (2024)
Midori Fujishiro, Sho Tanaka, Kentaro Watanabe, Kazuhiro Imatake, Yasuyuki Suzuki, Hisamitsu Ishihara, Shigemasa Tani
Association of Glycated Hemoglobin Level with Self-Reported Chewing Problems in Elderly Community-Dwelling Individuals in Japan. Journal of multidisciplinary healthcare 16 (2023)
Midori Fujishiro, Sho Tanaka, Kentaro Watanabe, Kazuhiro Imatake, Yasuyuki Suzuki, Hisamitsu Ishihara, Shigemasa Tani
Association of Glycated Hemoglobin Level with Self-Reported Chewing Problems in Elderly Community-Dwelling Individuals in Japan. Journal of multidisciplinary healthcare 16 (2023)
Kentaro Watanabe, Noe Takakubo, Taro Saigusa, Akiko Nagasawa, Midori Yamana, Midori Ojima, Wataru Kameda, Shinji Susa, Kenichi Ishizawa, Hisamitsu Ishihara
Fibrosis-4 Index Is Closely Associated with Arterial Damage and Future Risk of Coronary Heart Disease in Type 2 Diabetes. International journal of hypertension 2022 (2022)
Hisamitsu Ishihara
Metabolism-secretion coupling in glucose-stimulated insulin secretion. Diabetology international 13 (3) (2022)
Masao Koike, Hitoki Saito, Genta Kohno, Masahiro Takubo, Kentaro Watanabe, Hisamitsu Ishihara
Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages. International journal of molecular sciences 22 (21) (2021)
Chikako Ichikawa, Sho Tanaka, Masahiro Takubo, Masaru Kushimoto, Jin Ikeda, Katsuhiko Ogawa, Ichiro Tsujino, Yutaka Suzuki, Masanori Abe, Hisamitsu Ishihara, Midori Fujishiro
Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus. Therapeutics and clinical risk management 17 (2021)
Asami Furukawa, Aya Tanaka, Suguru Yamaguchi, Minami Kosuda, Midori Yamana, Akiko Nagasawa, Genta Kohno, Hisamitsu Ishihara
Using recombinase-mediated cassette exchange to engineer MIN6 insulin-secreting cells based on a newly identified safe harbor locus. Journal of diabetes investigation (2021)
Midori Fujishiro, Hisamitsu Ishihara, Katsuhiko Ogawa, Takayo Murase, Takashi Nakamura, Kentaro Watanabe, Hideyuki Sakoda, Hiraku Ono, Takeshi Yamamotoya, Yusuke Nakatsu, Tomoichiro Asano, Akifumi Kushiyama
Impact of Plasma Xanthine Oxidoreductase Activity on the Mechanisms of Distal Symmetric Polyneuropathy Development in Patients with Type 2 Diabetes. Biomedicines 9 (8) (2021)
Hisamitsu Ishihara, Susumu Yamaguchi, Toshifumi Sugitani, Yoshinori Kosakai
Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy. Clinical drug investigation 39 (12) (2020)
Toru Kitazawa, Hiroaki Seino, Hiroshi Ohashi, Takeshi Inazawa, Masahiro Inoue, Masumi Ai, Midori Fujishiro, Hisamoto Kuroda, Masayo Yamada, Motonobu Anai, Hisamitsu Ishihara
Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24-week, open-label, controlled trial (STOP-OB). Diabetes, obesity & metabolism 22 (9) (2020)
Sho Tanaka, Masanori Abe, Genta Kohno, Masaru Kushimoto, Jin Ikeda, Katsuhiko Ogawa, Yutaka Suzuki, Hisamitsu Ishihara, Midori Fujishiro
A Single Episode of Hypoglycemia as a Possible Early Warning Sign of Adrenal Insufficiency. Therapeutics and clinical risk management 16 (2020)
Hisamitsu Ishihara, Motonobu Anai, Hiroaki Seino, Toru Kitazawa, Hiroshi Ohashi, Masumi Ai, Masahiro Inoue, Midori Fujishiro, Takeshi Inazawa, Hisamoto Kuroda, Masayo Yamada
Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy. Diabetes therapy : research, treatment and education of diabetes and related disorders 9 (5) (2018)